US Patent 11013741 AXL kinase inhibitors and use of the same
Patent 11013741 was granted and assigned to Sumitomo Dainippon Pharma Oncology on May, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11013741 AXL kinase inhibitors and use of the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
